These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS. Nephron Clin Pract; 2008 May; 108(4):c298-304. PubMed ID: 18434752 [Abstract] [Full Text] [Related]
3. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial. Diepeveen SH, Verhoeven GW, Van Der Palen J, Dikkeschei LD, Van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF. J Intern Med; 2005 May; 257(5):438-45. PubMed ID: 15836660 [Abstract] [Full Text] [Related]
4. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients. Pereira EC, Bertolami MC, Faludi AA, Sevanian A, Abdalla DS. Free Radic Biol Med; 2004 Nov 01; 37(9):1440-8. PubMed ID: 15454283 [Abstract] [Full Text] [Related]
5. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C. J Ren Nutr; 2002 Jul 01; 12(3):183-9. PubMed ID: 12105816 [Abstract] [Full Text] [Related]
6. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis. Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S. Blood Purif; 2007 Jul 01; 25(5-6):457-65. PubMed ID: 18075247 [Abstract] [Full Text] [Related]
7. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Hultqvist M, Hegbrant J, Nilsson-Thorell C, Lindholm T, Nilsson P, Lindén T, Hultqvist-Bengtsson U. Clin Nephrol; 1997 Jan 01; 47(1):37-46. PubMed ID: 9021240 [Abstract] [Full Text] [Related]
8. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmeir J, Rimbach G, Wolffram S, Müller MJ. Br J Nutr; 2009 Oct 01; 102(7):1065-74. PubMed ID: 19402938 [Abstract] [Full Text] [Related]
10. Effect of calcineurin inhibitors on low-density lipoprotein oxidation. Cofan F, Cofan M, Campos B, Guerra R, Campistol JM, Oppenheimer F. Transplant Proc; 2005 Nov 01; 37(9):3791-3. PubMed ID: 16386540 [Abstract] [Full Text] [Related]
11. Alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats. Lexis LA, Fassett RG, Coombes JS. Basic Clin Pharmacol Toxicol; 2006 Jan 01; 98(1):68-73. PubMed ID: 16433894 [Abstract] [Full Text] [Related]
12. LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes. Matsui J, Tamasawa N, Tanabe J, Kasai N, Murakami H, Yamato K, Guan J, Suda T. Diabetes Res Clin Pract; 2004 Dec 01; 66(3):229-36. PubMed ID: 15536019 [Abstract] [Full Text] [Related]
13. Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation. Sampson MJ, Astley S, Richardson T, Willis G, Davies IR, Hughes DA, Southon S. Clin Sci (Lond); 2001 Sep 01; 101(3):235-41. PubMed ID: 11524040 [Abstract] [Full Text] [Related]
14. [Effects of alpha-tocopherol and beta-carotene on the oxidized low density lipoprotein induced by Cu2+]. Cheng X, Cui Y, Chen Y, Zhang X. Wei Sheng Yan Jiu; 2000 Jul 01; 29(4):229-31. PubMed ID: 12520927 [Abstract] [Full Text] [Related]
15. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women]. Somogyi A, Herold M, Kocsis I, Nagy G, Somfai G, Studinger P. Orv Hetil; 2005 Aug 28; 146(35):1813-8. PubMed ID: 16187540 [Abstract] [Full Text] [Related]
16. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H. Arterioscler Thromb Vasc Biol; 2005 Dec 28; 25(12):2615-22. PubMed ID: 16195474 [Abstract] [Full Text] [Related]
17. Association between circulating electronegative low-density lipoproteins and serum ferritin in hemodialysis patients: a pilot study. Lobo JC, Farage NE, Abdalla DS, Velarde LG, Torres JP, Mafra D. J Ren Nutr; 2012 May 28; 22(3):350-6. PubMed ID: 21741859 [Abstract] [Full Text] [Related]
18. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C. Metabolism; 2005 Jul 28; 54(7):856-61. PubMed ID: 15988692 [Abstract] [Full Text] [Related]
19. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients. Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Zoga M, Alevyzaki F, Stamatelou K, Frangou E, Savva L, Nicolaou C. Nephrology (Carlton); 2006 Dec 28; 11(6):506-9. PubMed ID: 17199788 [Abstract] [Full Text] [Related]
20. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? Van Hoydonck PG, Schouten EG, Manuel-Y-Keenoy B, van Campenhout A, Hoppenbrouwers KP, Temme EH. Eur J Clin Nutr; 2004 Dec 28; 58(12):1587-93. PubMed ID: 15127090 [Abstract] [Full Text] [Related] Page: [Next] [New Search]